John Gordon Freund - Net Worth and Insider Trading

John Gordon Freund Net Worth

The estimated net worth of John Gordon Freund is at least $106 Million dollars as of 2024-06-10. John Gordon Freund is the Director, 10% Owner of Collegium Pharmaceutical Inc and owns about 2,949,916 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $98 Million. John Gordon Freund is the Director of XenoPort Inc and owns about 502,486 shares of XenoPort Inc (XNPT) stock worth over $4 Million. John Gordon Freund is also the Director of Sutro Biopharma Inc and owns about 560,053 shares of Sutro Biopharma Inc (STRO) stock worth over $2 Million. Besides these, John Gordon Freund also holds SI-BONE Inc (SIBN) , Concert Pharmaceuticals Inc (CNCE) , Tetraphase Pharmaceuticals Inc (TTPH) . Details can be seen in John Gordon Freund's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John Gordon Freund has not made any transactions after 2023-08-09 and currently still holds the listed stock(s).

Transaction Summary of John Gordon Freund

To

John Gordon Freund Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Gordon Freund owns 10 companies in total, including SI-BONE Inc (SIBN) , Sutro Biopharma Inc (STRO) , and Collegium Pharmaceutical Inc (COLL) among others .

Click here to see the complete history of John Gordon Freund’s form 4 insider trades.

Insider Ownership Summary of John Gordon Freund

Ticker Comapny Transaction Date Type of Owner
SIBN SI-BONE Inc 2023-08-09 director & 10 percent owner
STRO Sutro Biopharma Inc 2020-09-18 director & 10 percent owner
COLL Collegium Pharmaceutical Inc 2022-05-19 director
LIMIT LIMIT 2019-12-10 director
LIMIT LIMIT 2014-10-21 10 percent owner
LIMIT LIMIT 2016-07-05 director
LIMIT LIMIT 2015-02-20 other: fomer 10% holder
LIMIT LIMIT 2012-05-29 10 percent owner
LIMIT LIMIT 2014-02-12 10 percent owner
LIMIT LIMIT 2009-06-17 director

John Gordon Freund Latest Holdings Summary

John Gordon Freund currently owns a total of 6 stocks. Among these stocks, John Gordon Freund owns 2,949,916 shares of Collegium Pharmaceutical Inc (COLL) as of May 12, 2015, with a value of $98 Million and a weighting of 92.75%. John Gordon Freund owns 502,486 shares of XenoPort Inc (XNPT) as of November 11, 2015, with a value of $4 Million and a weighting of 3.35%. John Gordon Freund also owns 560,053 shares of Sutro Biopharma Inc (STRO) as of September 18, 2020, with a value of $2 Million and a weighting of 2.04%. The other 3 stocks SI-BONE Inc (SIBN) , Concert Pharmaceuticals Inc (CNCE) , Tetraphase Pharmaceuticals Inc (TTPH) have a combined weighting of 1.87% among all his current holdings.

Latest Holdings of John Gordon Freund

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COLL Collegium Pharmaceutical Inc 2015-05-12 2,949,916 33.31 98,261,702
XNPT XenoPort Inc 2015-11-11 502,486 7.07 3,552,576
STRO Sutro Biopharma Inc 2020-09-18 560,053 3.85 2,156,204
SIBN SI-BONE Inc 2023-08-09 129,734 13.15 1,706,002
CNCE Concert Pharmaceuticals Inc 2014-02-12 32,372 8.37 270,954
TTPH Tetraphase Pharmaceuticals Inc 2019-12-10 0 2.20 0

Holding Weightings of John Gordon Freund


John Gordon Freund Form 4 Trading Tracker

According to the SEC Form 4 filings, John Gordon Freund has made a total of 0 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years. The most-recent trade in Collegium Pharmaceutical Inc is the acquisition of 150,000 shares on May 12, 2015, which cost John Gordon Freund around $2 Million.

According to the SEC Form 4 filings, John Gordon Freund has made a total of 0 transactions in XenoPort Inc (XNPT) over the past 5 years. The most-recent trade in XenoPort Inc is the sale of 909 shares on November 11, 2015, which brought John Gordon Freund around $6,072.

According to the SEC Form 4 filings, John Gordon Freund has made a total of 3 transactions in Sutro Biopharma Inc (STRO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Sutro Biopharma Inc is the sale of 400,000 shares on September 18, 2020, which brought John Gordon Freund around $5 Million.

More details on John Gordon Freund's insider transactions can be found in the Insider Trading History of John Gordon Freund table.

Insider Trading History of John Gordon Freund

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Gordon Freund Trading Performance

GuruFocus tracks the stock performance after each of John Gordon Freund's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Gordon Freund is 14.84%. GuruFocus also compares John Gordon Freund's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Gordon Freund within 3 months outperforms 9 times out of 11 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John Gordon Freund's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John Gordon Freund

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
7 out of 11 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.91 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 11.08 LIMIT LIMIT LIMIT LIMIT LIMIT

John Gordon Freund Ownership Network

Ownership Network List of John Gordon Freund

No Data

Ownership Network Relation of John Gordon Freund

Insider Network Chart

John Gordon Freund Owned Company Details

What does SI-BONE Inc do?

Who are the key executives at SI-BONE Inc?

John Gordon Freund is the director & 10 percent owner of SI-BONE Inc. Other key executives at SI-BONE Inc include Chief Commercial Officer Anthony J Recupero , director & Chairman & President & CEO Jeffrey W Dunn , and Chief Financial Officer Anshul Maheshwari .

SI-BONE Inc (SIBN) Insider Trades Summary

Over the past 18 months, John Gordon Freund made 1 insider transaction in SI-BONE Inc (SIBN) with a net sale of 30,000. Other recent insider transactions involving SI-BONE Inc (SIBN) include a net sale of 361,756 shares made by Jeffrey W Dunn , a net sale of 51,210 shares made by Anthony J Recupero , and a net sale of 22,401 shares made by Anshul Maheshwari .

In summary, during the past 3 months, insiders sold 22,856 shares of SI-BONE Inc (SIBN) in total and bought 0 shares, with a net sale of 22,856 shares. During the past 18 months, 535,349 shares of SI-BONE Inc (SIBN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 535,349 shares.

SI-BONE Inc (SIBN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

SI-BONE Inc Insider Transactions

No Available Data

John Gordon Freund Mailing Address

Above is the net worth, insider trading, and ownership report for John Gordon Freund. You might contact John Gordon Freund via mailing address: 125 University Ave., C/o Skyline Ventures, Palo Alto Ca 94301.

Discussions on John Gordon Freund

No discussions yet.